Insights from Global Analyses of Long Noncoding RNAs in Breast Cancer
- 207 Downloads
Purpose of Review
The goal of this review was to compare and contrast the results and implications from several recent transcriptomic studies that analyzed the expression of long noncoding RNAs (lncRNAs) in breast cancer. How many lncRNAs are dysregulated in breast cancer? Do dysregulated lncRNAs contribute to breast cancer etiology? Are lncRNAs viable biomarkers in breast cancer?
Transcriptomic profiling of breast cancer tissues, mostly from The Cancer Genome Atlas, identified thousands of long noncoding RNAs that are expressed and dysregulated in breast cancer. The expression of lncRNAs alone can divide patients into molecular subtypes. Subsequent functional studies demonstrated that several of these lncRNAs have important roles in breast cancer cell biology.
Thousands of lncRNAs are dysregulated in breast cancer that can be developed as biomarkers for prognostic or therapeutic purposes. The reviewed reports provide a roadmap to guide functional studies to discover lncRNAs with critical biological functions relating to breast cancer development and progression.
KeywordsLong noncoding RNAs Breast cancer Biomarkers The Cancer Genome Atlas Transcriptomics
Long noncoding RNA
Protein coding gene
Genome-wide association studies
The Cancer Genome Atlas
Triple-negative breast cancer
Single nucleotide polymorphism
We acknowledge Sreeroopa Som for her comments during the planning of the manuscript. We also thank our funding sources. DB was supported in part by a Susan G. Komen Foundation Fellowship. AW was supported in part through the Computer Science, Biology, and Biomedical Informatics and the University of Pittsburgh Cancer Institute Academies, which are supported through grants from the Doris Duke Foundation-Clinical Research Experiences for High School Students at the University of Pittsburgh (grant no. 2014154), the National Cancer Institute CURE Program (3P30CA047904-27S2), and support from the Jack Kent Cook Foundation and donations from UPMC and grateful parents and patients. Additionally, we would like to thank the team from the Department of Biomedical Informatics National Library of Medicine Training Program Grant in Biomedical Informatics (T15 LM007059), the University of Pittsburgh Cancer Institute (UPCI) Cancer Center Support Grant for the Cancer Bioinformatics Service (P30 CA47904), and the Clinical and Translational Science Institute Biomedical Informatics Core (UL1 RR024153).
Compliance with Ethical Standards
Conflict of Interest
Andrew Warburton and David Boone declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Recently published papers of particular interest have been highlighted as: • Of importance
- 1.American Cancer Society. Cancer facts and figures. 2016; 2016Google Scholar
- 25.Vennin C, Spruyt N, Dahmani F, Julien S, Bertucci F, Finetti P, Chassat T, Bourette RP, Le Bourhis X, Adriaenssens E (2015) H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. Oncotarget 6:29209–29223PubMedPubMedCentralGoogle Scholar
- 36.Sunwoo H, Dinger ME, Wilusz JE (2009) MEN ε/β nuclear retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspeckles. Genome Res 3:347–359Google Scholar
- 44.Mendell JT (2016) Targeting a long noncoding RNA in breast cancer. doi: 10.1056/NEJMcibr1603785
- 46.Henry WS, Hendrickson DG, Beca F, et al. LINC00520 is induced by Src, STAT3, and PI3K and plays a functional role in breast cancer. 2016 1:Google Scholar
- 66.American Cancer Society (2015) Cancer facts & figures 2015. Am. Cancer Soc., AtlantaGoogle Scholar
- 71.• Yan X, Hu Z, Feng Y et al (2015) Comprehensive genomic characterization of long non-coding RNAs across human cancers. Cancer Cell 28:529–540. This study provided a comprehensive portrait of lncRNAs across cancers. They describe lncRNAs altered in cancers at transcriptional, genomic, and epigenetic levels. PubMedPubMedCentralCrossRefGoogle Scholar
- 81.Niknafs YS, Han S, Ma T, Speers C, Zhang C, Wilder-Romans K, Iyer MK, Pitchiaya S, Malik R, Hosono Y, Prensner JR, Poliakov A, Singhal U, Xiao L, Kregel S, Siebenaler RF, Zhao SG, Uhl M, Gawronski A, Hayes DF, Pierce LJ, Cao X, Collins C, Backofen R, Sahi FF (2016) The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression. Nat Commun 7:12791PubMedPubMedCentralCrossRefGoogle Scholar
- 88.Jiang YZ, Liu YR, Xu XE, Jin X, Hu X, Yu K Da, Shao ZM (2016) Transcriptome analysis of triple-negative breast cancer reveals an integrated mRNA-lncRNA signature with predictive and prognostic value. Cancer Res 76:2105–2114Google Scholar
- 90.• Sun M, Gadad SS, Kim DS, Kraus WL (2015) Discovery, annotation, and functional analysis of long noncoding RNAs controlling cell-cycle gene expression and proliferation in breast cancer cells. Mol Cell 59:698–711. This study integrated steady-state RNAseq with GROSeq to define novel lncRNAs in MCF7 cells. PubMedPubMedCentralCrossRefGoogle Scholar
- 91.Sas-Chen A, Aure MR, Leibovich L et al (2016) LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer. EMBO Mol Med 39:e201606198Google Scholar
- 93.Sas-chen A, Aure MR, Leibovich L, et al. LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer. 2016 1–13Google Scholar
- 112.Yang X, Luo E, Liu X, Han B, Yu X, Peng X Delphinidin-3-glucoside suppresses breast carcinogenesis by inactivating the Akt/ HOTAIR signaling pathway. 2016. doi: 10.1186/s12885-016-2465-0
- 117.Gumireddy K, Li A, Yan J, et al. Identification of a long non-coding RNA-associated RNP complex regulating metastasis at the translational step. 2013 32:2672–2684Google Scholar
- 118.Xu C, Yang M, Ren Y, Wu C, Wang L. Exosomes mediated transfer of lncRNA UCA1 results in increased tamoxifen resistance in breast cancer cells. 2016 4362–4368Google Scholar
- 124.Chen F, Mo J, Zhang L Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription. Tumor Biol. doi: 10.1007/s13277-016-5256-y
- 127.Grembergen O Van, Bizet M, De Bony EJ, et al. Portraying breast cancers with long noncoding RNAs. 2016 1–16Google Scholar